Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMM

Canadian Myeloma Research Group · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
multiple-myelomaneoplasms
multiple myeloma, hematologic diseases, neoplasms, isatuximab, cyclophosphamide, dexamethasone, bortezomib, lenalidomide, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 914346
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.